Health Care And Pharma
Health Care and Pharma Law Firm in India for CDSCO Compliance
We advise healthcare and pharmaceutical clients in India on the regulatory, intellectual property, transactional and contentious work these sectors generate: CDSCO and Medical Council of India compliance, patents and trademarks over formulations and medical devices, clinical trial and research collaborations, patient data protection, and the disputes that arise from all of it.
Our Services
- Regulatory Compliance: Navigating web of regulations from the Central Drugs Standard Control Organization (CDSCO), Medical Council of India (MCI), and other relevant authorities.
- Intellectual Property Protection: Securing and defending patents, trademarks, and copyrights for pharmaceutical formulations, medical devices, and healthcare technologies.
- Corporate and Commercial Law: Structuring and executing mergers, acquisitions, and joint ventures; drafting and reviewing commercial agreements, including supply chain and distribution contracts.
- Clinical Trials and Research: Ensuring compliance with guidelines for conducting clinical trials and managing research collaborations.
- Data Protection and Privacy: Advising on data protection laws, particularly concerning patient data and clinical trial information.
- Dispute Resolution: Representing clients in litigation, arbitration, and mediation related to contract disputes, intellectual property infringements, and regulatory violations.
- Healthcare Facility Development: Assisting with the establishment and operation of hospitals, clinics, and other healthcare facilities, including real estate and construction law.
- Pharmaceutical Manufacturing: Providing legal support for manufacturing processes, including compliance with Good Manufacturing Practices (GMP) and other industry standards.
- Medical Devices Regulation: Ensuring compliance with regulations for the import, manufacture, and sale of medical devices.
- Health Insurance and Reimbursement: Advising on health insurance laws and reimbursement policies.
- Telemedicine and Digital Health: Navigating the legal framework for telemedicine services and digital health innovations.
- Pharmaceutical Pricing and Distribution: Advising on pricing strategies and distribution networks to ensure compliance with regulatory requirements.
- Product Liability: Managing product liability issues and recalls, ensuring compliance with consumer protection laws.
- Corporate Governance: Implementing strong corporate governance practices to ensure transparency and accountability in healthcare and pharma organizations.
- Environmental Compliance: Ensuring that pharmaceutical manufacturing processes comply with environmental regulations and standards.
- Healthcare Fraud and Abuse: Advising on laws related to healthcare fraud and abuse, including anti-kickback statutes and false claims acts.
- International Trade and Export: Providing legal support for the export of pharmaceutical products, including compliance with international trade regulations.
Key Highlights
What We Cover
- Regulatory: approvals and compliance before the Central Drugs Standard Control Organization, the Medical Council of India and allied authorities, across drugs, devices and healthcare facilities.
- Intellectual property: patents, trademarks and copyright over pharmaceutical formulations, medical devices and healthcare technologies.
- Clinical trials and research: trial compliance and research collaboration agreements.
- Data protection: patient data and clinical trial information.
- Transactions: mergers, acquisitions and joint ventures, plus supply chain and distribution contracts.
- Disputes: litigation, arbitration and mediation over contracts, IP infringement and regulatory action.
We act for hospitals, manufacturers and healthcare technology businesses from approval through commercialisation to enforcement.
Key Professionals
FAQs
What does a healthcare and pharma legal practice cover in India?
It covers regulatory compliance with CDSCO and MCI, intellectual property protection for drugs and devices, clinical trial governance, pharmaceutical manufacturing law, health insurance advisory, and dispute resolution across the healthcare value chain.
When should a healthcare or pharma company engage a specialized lawyer?
Ideally before launching a new drug, medical device, or clinical trial; entering a joint venture or acquisition; or setting up a manufacturing or hospital facility. Early legal involvement reduces the risk of regulatory delays, IP conflicts, and costly compliance gaps.
Which Indian regulators and statutes govern the healthcare and pharma sector?
Key regulators include CDSCO for drugs and clinical trials, the National Medical Commission (formerly MCI), and IRDAI for health insurance. Core statutes are the Drugs and Cosmetics Act 1940, the New Drugs and Clinical Trials Rules 2019, the Medical Devices Rules 2017, and the DPDP Act for patient data.
What is the typical timeline for obtaining a new drug approval from CDSCO?
Timelines vary by drug category. A new chemical entity may take 12 to 24 months after clinical trial completion, while a generic drug with established bioequivalence data can receive approval in 6 to 12 months. Incomplete filings or query responses are the most common cause of delays.
What documents are needed to begin a pharma regulatory engagement?
Typically, we need the drug or device dossier, existing CDSCO licenses, manufacturing site GMP certificates, clinical trial protocols if applicable, partnership or JV term sheets, and any prior correspondence with regulators. For IP matters, patent filing details and prior art searches are also required.
What common compliance mistakes do healthcare and pharma companies make?
Frequent pitfalls include operating without updated CDSCO manufacturing licenses, failing to report adverse events within mandatory timelines, ignoring Medical Devices Rules for software-based diagnostics, and mishandling patient data in ways that breach the DPDP Act and clinical trial consent norms.